373 related articles for article (PubMed ID: 24045940)
1. Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth.
Tanida S; Akita K; Ishida A; Mori Y; Toda M; Inoue M; Ohta M; Yashiro M; Sawada T; Hirakawa K; Nakada H
J Biol Chem; 2013 Nov; 288(44):31842-52. PubMed ID: 24045940
[TBL] [Abstract][Full Text] [Related]
2. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9.
Beatson R; Tajadura-Ortega V; Achkova D; Picco G; Tsourouktsoglou TD; Klausing S; Hillier M; Maher J; Noll T; Crocker PR; Taylor-Papadimitriou J; Burchell JM
Nat Immunol; 2016 Nov; 17(11):1273-1281. PubMed ID: 27595232
[TBL] [Abstract][Full Text] [Related]
3. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409
[TBL] [Abstract][Full Text] [Related]
4. A soluble form of Siglec-9 provides an antitumor benefit against mammary tumor cells expressing MUC1 in transgenic mice.
Tomioka Y; Morimatsu M; Nishijima K; Usui T; Yamamoto S; Suyama H; Ozaki K; Ito T; Ono E
Biochem Biophys Res Commun; 2014 Jul; 450(1):532-7. PubMed ID: 24924635
[TBL] [Abstract][Full Text] [Related]
5. Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells.
Jia Y; Yu H; Fernandes SM; Wei Y; Gonzalez-Gil A; Motari MG; Vajn K; Stevens WW; Peters AT; Bochner BS; Kern RC; Schleimer RP; Schnaar RL
J Allergy Clin Immunol; 2015 Mar; 135(3):799-810.e7. PubMed ID: 25747723
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 binds to MUC1-N-terminal domain and triggers recruitment of β-catenin in MUC1-expressing mouse 3T3 cells.
Tanida S; Mori Y; Ishida A; Akita K; Nakada H
Biochim Biophys Acta; 2014 Jun; 1840(6):1790-7. PubMed ID: 24561267
[TBL] [Abstract][Full Text] [Related]
7. Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E.
Siddiqui S; Schwarz F; Springer S; Khedri Z; Yu H; Deng L; Verhagen A; Naito-Matsui Y; Jiang W; Kim D; Zhou J; Ding B; Chen X; Varki N; Varki A
J Biol Chem; 2017 Jan; 292(3):1029-1037. PubMed ID: 27920204
[TBL] [Abstract][Full Text] [Related]
8. First Evidence for a Role of Siglec-8 in Breast Cancer.
Trebo A; Ditsch N; Degenhardt T; Kuhn C; Rahmeh M; Schmoeckel E; Mayr D; Czogalla B; Kolben T; Meister S; Mahner S; Jeschke U; Hester A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670444
[TBL] [Abstract][Full Text] [Related]
9. Binding of a sialic acid-recognizing lectin Siglec-9 modulates adhesion dynamics of cancer cells via calpain-mediated protein degradation.
Sabit I; Hashimoto N; Matsumoto Y; Yamaji T; Furukawa K; Furukawa K
J Biol Chem; 2013 Dec; 288(49):35417-27. PubMed ID: 24145038
[TBL] [Abstract][Full Text] [Related]
10. Siglec Signaling in the Tumor Microenvironment.
van Houtum EJH; Büll C; Cornelissen LAM; Adema GJ
Front Immunol; 2021; 12():790317. PubMed ID: 34966391
[TBL] [Abstract][Full Text] [Related]
11. Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma.
Santegoets KCM; Gielen PR; Büll C; Schulte BM; Kers-Rebel ED; Küsters B; Bossman SAJFH; Ter Laan M; Wesseling P; Adema GJ
Cancer Immunol Immunother; 2019 Jun; 68(6):937-949. PubMed ID: 30953118
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive Siglec-E ligands on mouse aorta are up-regulated by LPS via NF-κB pathway.
Liu H; Zheng Y; Zhang Y; Li J; Fernandes SM; Zeng D; Li X; Schnaar RL; Jia Y
Biomed Pharmacother; 2020 Feb; 122():109760. PubMed ID: 31918287
[TBL] [Abstract][Full Text] [Related]
13. mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.
Yu Z; Maoui M; Wu L; Banville D; Shen S
Biochem J; 2001 Feb; 353(Pt 3):483-92. PubMed ID: 11171044
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement.
Yokoi H; Choi OH; Hubbard W; Lee HS; Canning BJ; Lee HH; Ryu SD; von Gunten S; Bickel CA; Hudson SA; Macglashan DW; Bochner BS
J Allergy Clin Immunol; 2008 Feb; 121(2):499-505.e1. PubMed ID: 18036650
[TBL] [Abstract][Full Text] [Related]
15. Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1.
Chen GY; Brown NK; Wu W; Khedri Z; Yu H; Chen X; van de Vlekkert D; D'Azzo A; Zheng P; Liu Y
Elife; 2014 Sep; 3():e04066. PubMed ID: 25187624
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
Ikehara Y; Ikehara SK; Paulson JC
J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
[TBL] [Abstract][Full Text] [Related]
17. Multivalent Interactions of Human Primary Amine Oxidase with the V and C22 Domains of Sialic Acid-Binding Immunoglobulin-Like Lectin-9 Regulate Its Binding and Amine Oxidase Activity.
Elovaara H; Parkash V; Fair-Mäkelä R; Salo-Ahen OM; Guédez G; Bligt-Lindén E; Grönholm J; Jalkanen S; Salminen TA
PLoS One; 2016; 11(11):e0166935. PubMed ID: 27893774
[TBL] [Abstract][Full Text] [Related]
18. Immunoregulatory Siglec ligands are abundant in human and mouse aorta and are up-regulated by high glucose.
Zhang Y; Zheng Y; Li J; Nie L; Hu Y; Wang F; Liu H; Fernandes SM; Zhong Q; Li X; Schnaar RL; Jia Y
Life Sci; 2019 Jan; 216():189-199. PubMed ID: 30471282
[TBL] [Abstract][Full Text] [Related]
19. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
[TBL] [Abstract][Full Text] [Related]
20. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.
Yu H; Gonzalez-Gil A; Wei Y; Fernandes SM; Porell RN; Vajn K; Paulson JC; Nycholat CM; Schnaar RL
Glycobiology; 2017 Jul; 27(7):657-668. PubMed ID: 28369504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
